Praxis Precision Medicines, Inc. Common Stock (PRAX) Stock Price

PRAXStock

$241.76+48.58%52W

Market Cap$6.75B

P/E—

PEG Ratio—

Div yield—

Beta2.89

PRAX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-39.54%

Price vs S&P 500 (4W)-17.78%

VGM Score36.92

Book Value / Share (Quarterly)$48.04

P/TBV (Annual)1.99x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-10.97

Price vs S&P 500 (YTD)-29.90%

Net Profit Margin (TTM)-2137.48%

EPS (TTM)$-13.37

10-Day Avg Trading Volume0.56M

EPS Excl Extra (TTM)$-13.37

EPS (Annual)$-13.48

ROI (Annual)-34.54%

Cash / Share (Quarterly)$27.17

ROA (Last FY)-32.33%

EBITD / Share (TTM)$-14.60

ROE (5Y Avg)-120.07%

Operating Margin (TTM)-2340.29%

Cash Flow / Share (Annual)$-9.89

P/B Ratio5.03x

P/B Ratio (Quarterly)6.96x

Net Income / Employee (Annual)$-1,805,200

EV / Revenue (TTM)733.68x

Net Interest Coverage (TTM)-753.34x

ROA (TTM)-40.22%

EPS Incl Extra (Annual)$-13.48

Current Ratio (Annual)10.22x

Quick Ratio (Quarterly)15.46x

3-Month Avg Trading Volume0.47M

52-Week Price Return48.58%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$48.01

P/S Ratio (Annual)789.19x

Asset Turnover (Annual)0.02x

52-Week High$392.70

EPS Excl Extra (Annual)$-13.48

26-Week Price Return-29.64%

Quick Ratio (Annual)10.03x

13-Week Price Return-23.11%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)15.73x

Enterprise Value$6.28B

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-20.92%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-2137.48%

Cash / Share (Annual)$23.79

3-Month Return Std Dev55.85%

Net Income / Employee (TTM)$-1,943,600

ROE (Last FY)-34.54%

EPS Basic Excl Extra (Annual)$-13.48

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-13.37

ROI (TTM)-43.02%

P/S Ratio (TTM)789.19x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.54

Price vs S&P 500 (52W)33.05%

Year-to-Date Return-17.98%

5-Day Price Return-3.83%

EPS Normalized (Annual)$-13.48

ROA (5Y Avg)-90.66%

Net Profit Margin (Annual)-2137.48%

Month-to-Date Return-16.99%

Cash Flow / Share (TTM)$-1.79

EBITD / Share (Annual)$-14.49

Operating Margin (Annual)-2340.29%

ROI (5Y Avg)-120.07%

EPS Basic Excl Extra (TTM)$-13.37

P/TBV (Quarterly)6.96x

P/B Ratio (Annual)8.39x

Pretax Margin (TTM)-2137.48%

Book Value / Share (Annual)$34.85

Price vs S&P 500 (13W)-25.79%

Beta2.89x

Revenue / Share (TTM)$0.00

ROE (TTM)-43.02%

52-Week Low$154.45

vGradeF

mGradeB

vgmGradeD

PRAX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$3.69	-$2.87	+22.22%(+$0.82)
Q1 2026	May 7, 2026	-$3.68	-$3.20	+13.01%(+$0.48)
Q4 2025	Feb 19, 2026	-$3.13	-$3.50	-11.99%(-$0.37)
Q3 2025	Nov 5, 2025	-$3.49	-$3.36	+3.72%(+$0.13)
Q2 2025	Aug 4, 2025	-$3.36	-$3.31	+1.43%(+$0.05)

PRAX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.17

4.16

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78
MIRMMirum Pharmaceuticals, Inc. Common Stock	F	B	C	8.4x	44.0%	81.7%	—	$80.14

About Praxis Precision Medicines, Inc. Common Stock

Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company leverages two proprietary platforms, Cerebrum and Solidus, to advance a portfolio of four clinical-stage candidates targeting movement disorders and epilepsy, including Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen.

PRAX Next Earnings Report

Report dateNov 9, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$3.63

Revenue estimate$0

Also reporting on Nov 9, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

NEUNewMarket CorporationIndustrial Chemicals
AXTAAxalta Coating Systems Ltd.Paints & Coatings
EMNEastman Chemical CompanyPlastics & Resins
HXLHexcel CorporationPlastics & Resins
ELFe.l.f. Beauty, Inc.Cosmetics & Toiletries
LNTHLantheus Holdings, IncIn Vitro Diagnostics
ICLICL Group Ltd.Agricultural Chemicals
IOVAIovance Biotherapeutics, Inc. Common StockBiological Products

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$154.45

High$392.70